VISA/hVISA Confirmation

Confirmation of vancomycin intermediate Staphylococcus aureus (VISA) or heterogeneous vancomycin intermediate Staphylococcus aureus (hVISA) by Etest.

• Necrotizing pneumonia
• Skin and soft tissue infections

Pure culture.

N/A

Send cultures as growth on culture medium or in transport medium.

Shipping of specimens shall be done by a TDG certified individual in accordance with TDG regulations. For additional information regarding classification of specimens for the purposes of shipping, consult either Part 2 Appendix 3 of the TDG Regulations or section 3.6.2 of the IATA Dangerous Goods Regulations as applicable.

For additional guidance on the transport of infectious substances in other languages, please click on the link below.

http://www.who.int/ihr/capacity-strengthening/infectious-substances/en/

N/A

Completed Antimicrobial Resistance and Nosocomial Infections Requisition.

N/A

A combination of macro & GRD Etests are used to determine a positive or negative result for hVISA or VISA.

8 calendar days.

1. Walsh TR1, Bolmström A, Qwärnström A, Ho P, Wootton M, Howe RA, MacGowan AP, Diekema D. 2001. Evaluation of current methods for detection of staphylococci with reduced susceptibility to glycopeptides. J Clin Microbiol.  Jul;39(7):2439-44.
2. Yusof A, et al. 2008. Evaluation of a New Etest Vancomycin-Teicoplanin strip for detection of glycopeptide-intermediate Staphylococcus aureus (GISA), in particular heterogeneous GISA. J Clin Microbiol 46(9) 3042-3047.

Pathogen Safety Data Sheets: Infectious Substances – Staphylococcus aureus

Fact Sheet - Community-Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA)